BMS Taps Emory For Clinical Trials In Oncology, Other Areas
This article was originally published in The Pink Sheet Daily
Executive Summary
Bristol-Myers Squibb forms an alliance with Emory University to conduct mid- and late-stage trials in oncology, metabolics, hepatitis C, and immunoscience using BMS compounds.